0001415889-24-010291.txt : 20240404 0001415889-24-010291.hdr.sgml : 20240404 20240404164531 ACCESSION NUMBER: 0001415889-24-010291 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240402 FILED AS OF DATE: 20240404 DATE AS OF CHANGE: 20240404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH PATRICK F CENTRAL INDEX KEY: 0001890360 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39799 FILM NUMBER: 24823685 MAIL ADDRESS: STREET 1: C/O CERTARA, INC. STREET 2: 100 OVERLOOK CENTER, SUITE 101 CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Certara, Inc. CENTRAL INDEX KEY: 0001827090 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] ORGANIZATION NAME: 06 Technology IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 OVERLOOK CENTER, SUITE 101 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: (609) 716-7900 MAIL ADDRESS: STREET 1: 100 OVERLOOK CENTER, SUITE 101 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 form4-04042024_080424.xml X0508 4 2024-04-02 0001827090 Certara, Inc. CERT 0001890360 SMITH PATRICK F C/O CERTARA, INC. 100 OVERLOOK CENTER, SUITE 101 PRINCETON NJ 08540 false true false false PRESIDENT, DRUG DEV SOLUTIONS 1 Common Stock 2024-04-02 4 S 0 5264 16.76 D 59254 D Common Stock 2024-04-02 4 S 0 649 17.72 D 58605 D Common Stock 2024-04-02 4 S 0 3024 16.75 D 55581 D Common Stock 2024-04-02 4 S 0 328 17.67 D 55253 D Common Stock 2024-04-02 4 S 0 4740 16.77 D 50513 D Common Stock 2024-04-02 4 S 0 422 17.77 D 50091 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2023. This transaction was executed in multiple trades at prices ranging from $16.50 to $16.98. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $17.53 to $17.85. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $16.49 to $16.96. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $17.53 to $17.74. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $16.50 to $17.11. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $17.70 to $17.85. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Richard M. Traynor, as Attorney-in-Fact for Patrick F. Smith 2024-04-04